- Psychemedics Corporation Reports First Quarter 2024 Financial Results
- Psychemedics Corporation Reports 2023 Financial Results
- Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
- Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
- Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
- Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
- Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
More ▼
Key statistics
On Friday, Psychemedics Corp (PMD:NAQ) closed at 2.25, 9.22% above its 52-week low of 2.06, set on Nov 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.31 |
---|---|
High | 2.42 |
Low | 2.25 |
Bid | 0.936 |
Offer | 3.15 |
Previous close | 2.43 |
Average volume | 7.50k |
---|---|
Shares outstanding | 5.81m |
Free float | 4.49m |
P/E (TTM) | -- |
Market cap | 13.47m USD |
EPS (TTM) | -0.773 USD |
Annual div (ADY) | -- |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | May 24 2023 |
Div pay-date | Jun 08 2023 |
Data delayed at least 15 minutes, as of Jun 07 2024 20:33 BST.
More ▼